Axo-Lenti-Pd Gene Therapy For Parkinson'S Disease: Efficacy, Safety, And Tolerability Data From The Second Cohort In Open-Label Dose Evaluation Study Sunrise-Pd At 6 Months Post Administration

MOLECULAR THERAPY(2021)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要